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An Evolutionarily Conserved Pathway
Essential for Orsay Virus Infection of
Caenorhabditis elegans
Hongbing Jiang, Kevin Chen, Luis E. Sandoval, Christian Leung, David Wang
Departments of Molecular Microbiology and Pathology & Immunology, Washington University in St. Louis
School of Medicine, St. Louis, Missouri, USA
ABSTRACT Many fundamental biological discoveries have been made in Caeno-
rhabditis elegans. The discovery of Orsay virus has enabled studies of host-virus in-
teractions in this model organism. To identify host factors critical for Orsay virus in-
fection, we designed a forward genetic screen that utilizes a virally induced green
ﬂuorescent protein (GFP) reporter. Following chemical mutagenesis, two Viro (virus
induced reporter off) mutants that failed to express GFP were mapped to sid-3, a
nonreceptor tyrosine kinase, and B0280.13 (renamed viro-2), an ortholog of human
Wiskott-Aldrich syndrome protein (WASP). Both mutants yielded Orsay virus RNA lev-
els comparable to that of the residual input virus, suggesting that they are not per-
missive for Orsay virus replication. In addition, we demonstrated that both genes af-
fect an early prereplication stage of Orsay virus infection. Furthermore, it is known
that the human ortholog of SID-3, activated CDC42-associated kinase (ACK1/
TNK2), is capable of phosphorylating human WASP, suggesting that VIRO-2 may
be a substrate for SID-3 in C. elegans. A targeted RNA interference (RNAi) knock-
down screen further identiﬁed the C. elegans gene nck-1, which has a human or-
tholog that interacts with TNK2 and WASP, as required for Orsay virus infection.
Thus, genetic screening in C. elegans identiﬁed critical roles in virus infection for
evolutionarily conserved genes in a known human pathway.
IMPORTANCE Orsay virus is the only known virus capable of naturally infecting the
model organism Caenorhabditis elegans, which shares many evolutionarily conserved
genes with humans. We exploited the robust genetic tractability of C. elegans to
identify three host genes, sid-3, viro-2, and nck-1, which are essential for Orsay virus
infection. Mutant animals that lack these three genes are highly defective in viral
replication. Strikingly, the human orthologs of these three genes, activated CDC42-
associated kinase (TNK2), Wiskott-Aldrich syndrome protein (WASP), and noncatalytic
region of tyrosine kinase adaptor protein 1 (NCK1) are part of a known signaling
pathway in mammals. These results suggest that TNK2, WASP, and NCK1 may play
important roles in mammalian virus infection.
KEYWORDS Caenorhabditis elegans, Orsay virus, TNK2, WASP, sid-3, viro-2
Viruses are obligate intracellular pathogens that are dependent upon host cellmachinery and resources to fulﬁll their parasitic life cycle. Although great strides
have been made in our understanding of many aspects of viral life cycles, there remain
many unanswered questions in fundamental virology. Model organisms provide reduc-
tionist systems that can circumvent challenges posed by the complexity of mammalian
systems. While Caenorhabditis elegans has played a critical role in the discoveries of
evolutionarily conserved processes such as RNA interference (RNAi) (1), its use in the
study of host-virus interactions has been limited by a lack of viruses capable of infecting
C. elegans. The recent discovery of Orsay virus, the ﬁrst natural viral pathogen of
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C. elegans, has provided a unique opportunity to exploit this classic model organism to
identify host factors critical for virus infection (2, 3).
Orsay virus is a nonenveloped virus with a positive-sense bipartite genome that is
most closely related to members of the family Nodaviridae (3). The virus genome
encodes an RNA-dependent RNA polymerase (RdRp) in the RNA1 segment, while the
RNA2 segment encodes the viral capsid protein and a capsid-delta fusion protein of
unknown function that is generated by a ribosomal frameshifting mechanism (4). Orsay
virus infects primarily C. elegans intestinal cells (5) and leads to morphological disrup-
tions of the intestine (3). In the laboratory, experimental infection can be achieved by
simply adding Orsay virus to the bacterial lawn upon which C. elegans feeds. In terms
of antiviral immunity, the roles for RNAi (6, 7) and the ubiquitin proteasome pathway
(8) have been identiﬁed. Furthermore, there are speciﬁc transcriptional responses to
Orsay virus infection (8–10). However, little is known about the Orsay virus life cycle. For
example, it is not clear what receptor(s) is used by Orsay virus, how it enters the host
cells, where the virus establishes replication inside the cells, or how it egresses and
spreads. To begin to address these questions, we designed a forward genetic screen
to identify in unbiased fashion host factors that are critical to support Orsay virus
infection. Here we describe two genes, sid-3, a nonreceptor tyrosine kinase, and
B0280.13 (renamed viro-2), a C. elegans ortholog of human Wiskott-Aldrich syndrome
proteins (WASPs), which are essential in C. elegans for Orsay virus infection. A further
targeted RNAi knockdown determined that nck-1, a C. elegans ortholog of the human
noncatalytic region of tyrosine kinase adaptor protein 1 (NCK1), was also essential for
Orsay virus infection in C. elegans. The human orthologs of these three genes are part
of a known kinase signaling pathway (11–13), suggesting that the genes in C. elegans
likewise form a pathway.
RESULTS
A forward genetic screen identiﬁed host factors essential for Orsay virus
infection in C. elegans. To identify host factors important for Orsay virus infection in
C. elegans, a forward genetic screen was designed using a previously described
transcriptional green ﬂuorescent protein (GFP) reporter strain that is induced by Orsay
virus infection (8). This strain, which carries an integrated transgene comprised of the
promoter of the pals-5 gene, a gene strongly induced by Orsay virus infection (8, 10),
fused to GFP, was crossed into the virus hypersensitive rde-1 mutant genetic back-
ground to generate a jyIs8;rde-1 reporter strain that typically leads to GFP expression in
99% of the animals following Orsay virus infection. Using ethane methylsulfonate
(EMS) chemical mutagenesis, the goal was to identify mutants that fail to activate GFP
expression after Orsay virus infection (Viro [virus induced reporter off] mutants). Mu-
tants with this phenotype could be defective in either their ability to support Orsay
virus infection or in the pathway that leads to transcriptional activation of GFP
expression.
Approximately 8,000 EMS-mutagenized haploid genomes were screened. Initial Viro
hits were rescreened to remove false-positive results (see Fig. S1 in the supplemental
material). These strains were bleached and subjected to another round of de novo Orsay
virus infection, yielding three independent Viro mutants (Fig. 1A). Crossing of the Viro
mutants with the unmutagenized reporter strain demonstrated that the Viro pheno-
type was transmitted as a simple recessive Mendelian trait in all three strains (data not
shown). Pairwise mating further demonstrated that these three strains represented
three distinct complementation groups, Viro-1, Viro-2, and Viro-3. As described in detail
below, a mutation was identiﬁed in the sid-3 gene (vir9 allele) in Viro-1, and a mutation
was identiﬁed in the B0280.13 gene (vir10 allele) in Viro-2. The B0280.13 gene was
subsequently renamed viro-2. Hereafter, these mutants are referred to as sid-3(vir9) and
viro-2(vir10) mutants or strains.
Orsay virus RNA levels in these strains were determined by real-time quantitative
reverse transcription-PCR (qRT-PCR). The sid-3(vir9) and viro-2(vir10) mutants yielded
very low levels of Orsay virus RNA (Fig. 1B). These levels were even lower than the
Jiang et al. ®
September/October 2017 Volume 8 Issue 5 e00940-17 mbio.asm.org 2
 
m
bio.asm
.org
 o
n
 D
ecem
ber 23, 2017 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
FIG 1 A forward genetic screen identiﬁed mutant strains defective in GFP expression and Orsay virus
replication. (A) GFP reporter expression patterns of Viro mutants after Orsay virus or N. parisii infection.
BF, bright-ﬁeld microscopy. Bars, 200 m. (B) Orsay virus RNA levels quantiﬁed by real-time qRT-PCR.
Values are means plus standard deviations (error bars) for three replicate wells. Values that were
signiﬁcantly different (P  0.0005) are indicated by a bar and asterisks (****). Values that were not
signiﬁcantly different (P  0.05) (NS) are indicated.
sid-3 and viro-2 Support Orsay Virus Infection ®
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amount of Orsay virus RNA detected when input virus was incubated in an empty well
for the duration of the experiment and then mixed with a uninfected well of animals
immediately prior to RNA extraction (Fig. 1B, bar labeled “Decay”). This control mea-
sures the extent of spontaneous degradation of the input virus in the absence of any
replication (since no host animals are available to support replication), but it fails to
account for any possible negative impact of C. elegans (physical movement, feeding,
defecation, etc.) on the viral nucleic acid stability on the plate during the course of an
authentic infection. Thus, the “decay control” is an upper limit estimate of the amount
of residual input Orsay virus RNA. In contrast, Viro-3 Orsay virus RNA levels were similar
to that of the unmutagenized parent, suggesting that the defect in Viro-3 affects the
pathway necessary for the transcriptional activation of the GFP reporter. In this study,
we focused on analysis of sid-3(vir9) and viro-2(vir10) mutants.
As the GFP expression in the parental reporter strain can also be induced by
infection by Nematocida parisii, a microsporidial pathogen of C. elegans (8), we chal-
lenged sid-3(vir9), viro-2(vir10), and Viro-3 mutants with N. parisii. All three mutants still
induced GFP expression in the intestinal cells, demonstrating that the GFP transgene
was still functional and the virus-speciﬁc nature of the Viro phenotype (Fig. 1A).
Mutation in the sid-3 gene is responsible for Viro-1 phenotypes. To identify the
mutation responsible for the lack of GFP expression in the Viro-1 mutant, F2 bulk
segregant analysis (14, 15) was performed by outcrossing the strain with the rde-
1(ne219) mutant strain, which is highly susceptible to Orsay virus infection. Approxi-
mately 50 F2 progenies that had the Viro phenotype and that did not support Orsay
virus replication (data not shown) were identiﬁed. The F3 progenies were pooled,
sequenced, and analyzed using the CloudMap bioinformatic pipeline (16). Typical
mutations introduced by EMS were found in the linked region on chromosome X,
including a C-to-T nonsense mutation in the coding region of the sid-3 (systemic RNAi
defective) gene. This mutation leads to a premature stop after amino acid 911 of the
SID-3 protein (Fig. S2). sid-3 encodes a nonreceptor tyrosine kinase that was originally
identiﬁed in a genetic screen for animals defective in systemic RNAi (17). In C. elegans,
sid-3 is thought to play a role in endosomal import of double-stranded RNA (17).
Orthologs of sid-3 are present in a wide range of organisms (Fig. 2A); the human
ortholog ACK1/TNK2 has a wide range of reported substrates for its kinase activity (18,
19) and has been implicated in various cancers (18, 20).
Several additional lines of evidence demonstrated that sid-3 was the gene respon-
sible for the observed phenotypes in the Viro-1 strain. First, we performed targeted
feeding RNAi knockdown of sid-3 in the drh-1 mutant background. While this strain is
defective in antiviral RNAi which makes it highly susceptible to Orsay virus infection, it
is competent for exogenous feeding RNAi (21). RNAi knockdown of sid-3 resulted in an
approximately 2-log-unit reduction of virus RNA compared to the empty RNAi feeding
vector or knockdown of a nonrelated host gene, dpy-3 (Fig. 3). sid-3 RNAi in the
wild-type N2 background yielded a similar reduction in Orsay virus RNA (Fig. S4). In
addition, a strain carrying an independent allele of sid-3, VC787 (ok973), harboring a
1-kb deletion was obtained from the Caenorhabditis Genetics Center (Fig. S2) and
crossed with the jyIs8;rde-1 reporter strain. This strain phenocopied the sid-3(vir9)
mutant in terms of both GFP expression and Orsay RNA levels (Fig. 4A and B). Similarly,
direct infection of sid-3(ok973) mutant yielded little or no virus replication (Fig. S3).
Finally, ectopic expression of wild-type SID-3 from a plasmid driven by the ubiquitous
sur-5 gene promoter rescued the GFP and Orsay virus RNA level phenotypes and
partially rescued the virus-induced gene F26F2.1 (10) expression phenotype (Fig. 2C and
D and Fig. S9) as did a fosmid encompassing the sid-3 locus (data not shown). These
data clearly implicated sid-3 as the gene responsible for the defective GFP expression
and reduced Orsay virus RNA levels.
To determine whether the kinase activity of SID-3 was required to complement the
Viro phenotype, we ectopically expressed SID-3 carrying a K139A mutation in the
catalytic domain that is predicted to abolish its kinase activity in the sid-3(vir9) mutant.
Jiang et al. ®
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This mutant form of SID-3 had previously failed to rescue the systemic RNAi defect in
the sid-3(ok973) mutant (17). Animals expressing the K139A SID-3 from a sur-5 promoter
failed to rescue either the GFP or RNA phenotype, suggesting that the kinase activity
of SID-3 is critical (Fig. 2C and D). In order to rule out any effects of the K139A mutation
on SID-3 expression or stability, we expressed C-terminal mCherry fusions of both
wild-type and K139A SID-3. As expected, the C-terminal mCherry fusion of the wild-type
FIG 2 Impact of ectopic expression of SID-3 in sid-3(vir9) mutant on Orsay virus replication and GFP expression. (A) Neighbor-joining phylogenetic tree of SID-3
orthologs from humans (Homo sapiens) and multiple model organisms. The model organisms include Gallus gallus, Danio rerio, Xenopus tropicalis, Drosophila
melanogaster, Saccharomyces pombe, and Mus musculus. The bar indicates the amino acid substitution rate (0.1 amino acid substitution per position). (B)
Schematic representation of protein domain organization of C. elegans SID-3 and human TNK2. (C) Imaging of Orsay virus-infected sid-3(vir9) mutant that
overexpressed wild-type SID-3 or the K139A kinase catalytic domain mutant. BF, bright-ﬁeld microscopy. Bars, 200 m. (D) Real-time qRT-PCR of Orsay
virus-infected sid-3(vir9) mutant that overexpressed wild-type SID-3 or the K139A kinase catalytic domain mutant. **, P  0.01; NS, not signiﬁcant (P  0.05).
FIG 3 RNAi knockdown of candidate causal genes in drh-1 mutant strain. Real-time qRT-PCR of Orsay
virus RNA levels after feeding RNAi knockdown of individual genes. ***, P 0.005; NS, not signiﬁcant (P
0.05).
sid-3 and viro-2 Support Orsay Virus Infection ®
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SID-3, but not the K139A mutant, rescued the GFP and RNA phenotypes (Fig. S5). The
level of expression of the K139A SID-3 mutant was higher than the level of expression
of wild-type SID-3 as quantiﬁed by mCherry expression, demonstrating that the inabil-
ity of the mutant to rescue the phenotype was not due to lack of protein expression
(Fig. S5).
Mutation in the B0280.13 (viro-2) gene is responsible for Viro-2 phenotypes.
Two candidate mutations in a linked region of chromosome III were identiﬁed in
viro-2(vir10) mutants: a C-to-T mutation which results in a premature stop codon at
amino acid position 574 in the B0280.13 gene (viro-2) and a similar mutation at amino
acid position 164 in the adr-2 gene (adenosine deaminase acting on RNA gene 2). The
viro-2 gene encodes an ortholog of the human N-WASP (Fig. 5A and B). WASP is an
important nucleator of actin polymerization and affects many cellular processes (22). In
the context of virus infections, N-WASP is known to be important for egress and spread
of vaccinia virus (23, 24). ADR-2 is an RNA-editing enzyme that deaminates adenosines
to inosines in double-stranded RNA (dsRNA), and roles for ADR as a proviral factor have
been reported (25). To determine which of these genes was responsible for the
observed phenotypes, we knocked down both genes using RNAi. RNAi knockdown of
viro-2 yielded a 2-log-unit reduction in Orsay virus RNA levels, while knockdown of
adr-2 gave levels similar to that of the empty RNAi feeding vector, suggesting that the
mutation in viro-2 is responsible for the observed phenotype in this strain (Fig. 3). An
independent mutant, viro-2(gk627069), which harbors a premature stop codon at amino
acid position 246 in the C terminus of the viro-2 gene product, was obtained from the
million mutation project (26). After crossing of the strain with the jyIs8;rde-1 strain,
Orsay virus challenge failed to induce GFP (Fig. 4A) and resulted in levels of Orsay RNA
similar to those seen in the viro-2(vir10) strain (Fig. 4B). Overexpression of wild-type
VIRO-2 in the viro-2(vir10) mutant from a microinjected plasmid rescued both the GFP
and Orsay virus RNA levels (Fig. 5C and D), as did overexpression of a genomic fragment
that contains the viro-2 gene locus (data not shown). Similar results were obtained with
a plasmid expressing a C-terminal mCherry fusion of VIRO-2 (Fig. S6). On the basis of
these experiments, we conclude that the mutation in viro-2 is responsible for the Viro-2
phenotypes.
Furthermore, a double mutant that carried both sid-3 and viro-2 gene mutations was
generated by crossing the sid-3(vir9) and viro-2(vir10) strains. Orsay virus infection of the
double mutant showed RNA levels similar to those of sid-3(vir9) or viro-2(vir10) single
mutant alone (Fig. 1B). As the Orsay virus RNA levels in the single mutants and the
double mutant were essentially not detected, no deﬁnitive conclusion regarding
potential epistasis could be made.
Orsay virus replication initiated from an endogenous transgene bypasses the
requirements for SID-3 and VIRO-2. We previously established a two-plasmid cDNA-
based reverse genetic system to generate recombinant Orsay virus (27). In this system,
FIG 4 Infection of strains carrying independent mutant alleles of sid-3 and viro-2. (A) GFP expression patterns of reporter strains that carry independent mutant
alleles of sid-3 and viro-2. BF, bright-ﬁeld microscopy. Bars, 200 m. (B) Quantiﬁcation of Orsay virus RNA levels by real-time qRT-PCR. *****, P  0.00005.
Jiang et al. ®
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Orsay virus RNA1 and RNA2 segments are each expressed under the control of the heat
shock promoter, and injection of both plasmids together leads to formation of recom-
binant Orsay virus. Strains carrying RNA1 alone, which express the RdRp, are competent
to support replication of the Orsay virus RNA1 segment as a replicon system. When we
microinjected only the plasmid expressing RNA1 into the jyIs8;rde-1 strain, the resulting
strain expressed GFP after heat shock (Fig. 6A). In contrast, microinjection of a plasmid
that expresses RNA1 with a D601A mutation in the conserved GDD motif of the RdRp
failed to induce GFP expression (Fig. 6A). The former result demonstrates that induction
of the plasmid expressing wild-type RNA1 is sufﬁcient to activate GFP expression, while
the latter result with the mutant RdRp construct strongly suggests that Orsay virus
replication is necessary to activate GFP. To assess the impact of SID-3 on the Orsay virus
replicon, we separately microinjected the PHIP::RNA1 and PHIP::RNA1D601A mutant
constructs into the sid-3(vir9) background to generate extrachromosomal array carrying
strains. Heat shock of strain sid-3(vir9);virEx23[PHIP::RNA1WT] [sid-3(vir9) strain harbor-
ing wild-type RNA1] activated GFP expression. Furthermore, increased Orsay RNA1
levels were observed compared to analogous sid-3(vir9);virEx26[PHIP::RNA1D601A] [sid-
3(vir9) strain harboring the D601A replication-incompetent RNA1] demonstrating that
Orsay virus RNA1 replication can occur in the absence of SID-3 (Fig. 6C). These results
suggest that SID-3 is not required for Orsay virus RNA1 replication initiated from an
endogenous transgene.
FIG 5 Impact of ectopic expression of VIRO-2 in the viro-2(vir10) mutant on Orsay virus replication and GFP expression. (A) Neighbor-joining
phylogenetic tree of VIRO-2 orthologs from human and multiple model organisms. The bar indicates the amino acid substitution rate (0.1 amino
acid substitution per position). (B) Schematic representation of protein domain organization for C. elegans VIRO-2 and human N-WASP. (C) GFP
expression after ectopic VIRO-2 expression in Viro-2. BF, bright-ﬁeld microscopy. Bars, 200 m. (D) Real-time qRT-PCR of Orsay virus-infected
viro-2(vir10) mutant that overexpressed VIRO-2. **, P  0.01.
sid-3 and viro-2 Support Orsay Virus Infection ®
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FIG 6 Impact of sid-3 and viro-2 on Orsay virus RNA1 transgene-initiated replication. (A) Imaging of
heat-induced strains carrying either wild-type or mutant Orsay virus RNA1 in the jyIs8;rde-1 background.
BF, bright-ﬁeld microscopy. Bars, 200 m. (B) Imaging of heat-induced strains carrying either wild-type
or mutant Orsay virus RNA1 in the sid-3(vir9) background. Bars, 200 m. (C) Quantiﬁcation of Orsay RNA1
replication from heat-induced transgenic C. elegans. To control for possible variability in the copy number
of the extrachromosomal arrays, two independent lines for each plasmid construct were tested. NS, not
signiﬁcant (P  0.05).
Jiang et al. ®
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To conﬁrm these observations in the context of a transgenic system capable of
generating recombinant Orsay virus, we generated a stably integrated line (virIs1;rde-1)
harboring both Orsay virus RNA1 and RNA2. The virIs1;rde-1 strain was then crossed
with the jyIs8;rde-1 strain to yield the virIs1;jyIs8;rde-1 strain. The virIs1;jyIs8;rde-1 strain
was further crossed with either the sid-3(vir9) or viro-2(vir10) strain to generate the
virIs1;jyIs8;rde-1;sid-3(vir9) or virIs1;jyIs8;rde-1;viro-2(vir10) strain, respectively. When chal-
lenged with exogenous Orsay virus, virIs1;jyIs8;rde-1;sid-3(vir9) and virIs1;jyIs8;rde-1;viro-
2(vir10) strains failed to induce GFP as expected (Fig. S7A). However, heat induction led
to expression of GFP, despite the absence of SID-3 or VIRO-2 in these strains (Fig. S7B).
These results demonstrate that SID-3 and VIRO-2, while required to induce GFP in
response to exogenous virus, are dispensable for induction of GFP in strains that initiate
Orsay replication from integrated transgenes. These results suggest that SID-3 and
VIRO-2 act at an early stage of the Orsay virus life cycle prior to viral replication.
SID-3 and VIRO-2 colocalize to the apical side of the intestine. The human
orthologs of SID-3 and VIRO-2 are reported to be a kinase-substrate pair through in vitro
biochemical studies (19). However, to date, there is no data as to whether SID-3
phosphorylates VIRO-2 in C. elegans. Since kinases and their direct substrates must
colocalize at some point in time, we asked whether we could detect colocalization
of SID-3 and VIRO-2. To this end, we generated strains that express SID-3
C-terminally fused with yellow ﬂuorescent protein (YFP) and VIRO-2 C-terminally
fused with mCherry, each driven by the universal sur-5 gene promoter. Both proteins
were detected in somatic cells with stronger expression observed in the intestinal cells.
Both tagged proteins were functional, as they rescued the Orsay virus RNA level
phenotype when coinjected into the sid-3(vir9);viro-2(vir10) double mutant (data not
shown). Colocalization of these two proteins, especially along the apical side of the
intestine, was observed in transgenic strains that were infected by Orsay virus (Fig. 7A
and B and Fig. S8).
RNAi knockdown deﬁnes a role for nck-1 in Orsay virus infection. Little is known
about C. elegans proteins that interact with SID-3 or VIRO-2. In humans, multiple
interacting partners of TNK2 and WASP have been deﬁned (12, 13, 28–30). In C. elegans,
wsp-1 is another WASP ortholog, and several proteins that interact with wsp-1 have
been identiﬁed (31, 32). To determine whether wsp-1, the C. elegans orthologs of genes
that interact with TNK2 (lst-1, dhs-7, and nck-1), or C. elegans genes that interact with
WSP-1 (mig-13, mig-2, and nck-1) affect Orsay virus infection, we performed RNAi
knockdown and evaluated Orsay virus replication. Of these tested genes, nck-1, the
C. elegans ortholog of human NCK1, yielded an approximately 3-log-unit reduction in
Orsay virus RNA. These RNA levels are even lower than those observed by RNAi
knockdown of sid-3 and viro-2 (Fig. 8), which may reﬂect differences in the relative
efﬁciency of knockdown of the genes. To validate the RNAi result, a strain carrying a
mutant allele of nck-1 (ok694) was crossed with a jyIs8;rde-1 strain and yielded virus
levels similar to those of sid-3(vir9) and viro-2(vir10) mutant strains when infected by
Orsay virus (Fig. 1B). In humans, NCK1 is known to directly bind to both TNK2 (12) and
WASP (13), and it is known to play a role in vaccinia virus egress and spreading (24).
Together, these data suggest that sid-3, viro-2, and nck-1 function in a pathway that
plays a critical role in Orsay virus infection in C. elegans.
DISCUSSION
In this study, we identiﬁed two genes that are important for Orsay virus infection of
C. elegans from a small-scale (~8,000 haploid genomes) EMS screen. A third host gene
was subsequently identiﬁed by additional targeted RNAi screening. As the current EMS
screen is far from saturation, additional EMS screening is likely to identify more host
factors that play critical roles in Orsay virus infection. From a technical perspective, the
use of a GFP reporter renders the screen essentially binary, thereby facilitating large-
scale screening.
Neither sid-3 nor viro-2 has been extensively studied in C. elegans. To date, there is
only one published study on sid-3 that deﬁned a role in endosomal trafﬁcking in the
sid-3 and viro-2 Support Orsay Virus Infection ®
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FIG 7 SID-3 and VIRO-2 colocalize in transgenic strains. (A and B) Confocal microscopy of a representative animal of the
rde-1(ne219) strain (sid-3::YFP and viro-2::mCherry fusion proteins driven by the universal sur-5 gene promoter) 48 h after Orsay
virus infection. BF, bright-ﬁeld microscopy. Bars, 10 m. The zoomed-in area shown in the micrograph in panel B is indicated
by the magenta box in panel A. The graph in panel B shows ﬂuorescence intensity (in AU [arbitrary unit]) on the y axis and
distance (in nm) on the x axis. The graph shows ﬂuorescence intensity proﬁling of the position marked by the magenta arrow.
The intestinal apical side is indicated in the graph by a black bar.
FIG 8 RNAi knockdown of candidate genes. Real-time qRT-PCR of Orsay virus RNA levels after feeding
RNAi knockdown of individual genes. *, P  0.05; NS, not signiﬁcant (P  0.05).
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context of systemic RNAi (17) and no explicit published study of viro-2. Despite the
paucity of knowledge regarding these two genes, much can be inferred from studies of
mammals and their orthologs. The human ortholog of sid-3, TNK2, has many functions,
and multiple substrates for its kinase activity have been identiﬁed including N-WASP,
clathrin, and androgen receptor (12, 18, 19, 33). The identiﬁcation of sid-3 in this screen
suggests a possible role for its human ortholog, TNK2, in virus infection. While there are
no publications thus far that have focused explicitly on the role of TNK2 in the context
of virus infection, it has been identiﬁed as a hit in multiple large-scale small interfering
RNA (siRNA) screens for inﬂuenza A virus (IAV), hepatitis C virus (HCV), and vesicular
stomatitis virus (VSV) (34–37). Thus, an unbiased screen of C. elegans has identiﬁed an
evolutionarily conserved gene that may impact virus infection in a range of hosts.
Orsay virus RNA levels in the strains with the two sid-3 alleles, vir9 and ok973, were
5 to 6 log units lower than those detected in the parental strain [jyIs8;rde-1(ne219)]
(Fig. 1B and 4B). Given that the observed RNA levels are lower than the decay, they may
represent either very low levels of Orsay virus replication or more likely, simply residual
input Orsay virus. On the basis of our observations, we hypothesize that sid-3 is
essential for Orsay virus infection at an early step of the life cycle. The fact that Orsay
virus replication initiated from an integrated transgene can still activate GFP expression
in the absence of sid-3 demonstrates that viral replication itself does not formally
require sid-3; thus, it is likely that sid-3 acts at a stage preceding virus replication.
Furthermore, several of the siRNA screens that identiﬁed TNK2 as a host factor impor-
tant for mammalian virus were speciﬁcally designed to detect only genes important for
early steps of viral life cycles (34, 36, 38, 39). Collectively, these data suggest that SID-3
(and TNK2) may play roles in early stages such as viral entry; since TNK2 is known to
bind directly to clathrin (12), one possibility is that TNK2 and/or SID-3 could modulate
clathrin-mediated endocytosis.
While mutations in viro-2 phenocopy mutations in sid-3 in terms of both GFP
phenotype and Orsay virus RNA levels, the genes encode very different proteins. viro-2
is one of four C. elegans orthologs (along with B0280.2, wsp-1, and C31C9.6) of the two
human WASP proteins (WASP and N-WASP). VIRO-2 shares an EVH1/WH1 domain with
human WASP proteins (Fig. 5B). Wiskott-Aldrich syndrome is characterized by immune
dysregulation in humans (40, 41) caused by a deﬁciency of WASP, which is expressed
primarily in hematopoietic cell lineages. N-WASP is ubiquitously expressed in multiple
tissue types. WASP proteins are cytoplasmic with several conserved domains. Of the
conserved domains, the C-terminal VCA (verprolin homology, central and acidic re-
gions) domain is involved in regulation of actin polymerization. Normally, the VCA
domain of WASP binds to its central GBD (G protein binding domain) and renders this
protein inactive. Phosphorylation by a cytosolic kinase combined with either GTP-
activated CDC42 or SH2/SH3 domain-containing protein binding synergistically acti-
vates N-WASP. This leads to the recruitment of the Arp2/3 complex through its VCA
domain initiating actin polymerization and branching (22, 41). There is clear data in
human cells demonstrating that vaccinia virus egress and spread are dependent on
N-WASP (23, 24). In addition, N-WASP was recently found to play a role in the entry of
Lassa virus (42). Given the known ability of WASP proteins to regulate actin polymer-
ization and the need for actin remodeling in many facets of endosomal trafﬁcking (22),
a similar role for VIRO-2 in modulating some aspect of endosomal trafﬁcking of Orsay
virus is quite plausible, although it is not yet known whether VIRO-2 impacts actin.
Strikingly, the human orthologs of the two C. elegans genes identiﬁed in this genetic
screen have been demonstrated in vitro to be part of a kinase-substrate pathway (19).
This ﬁnding underscores the power of genetic analysis in model organisms and strongly
suggests that sid-3 and viro-2 may function in a common pathway in C. elegans. Our
experiments suggest that the kinase activity of SID-3 is important for its ability to
promote Orsay virus infection. It is possible that SID-3 directly phosphorylates VIRO-2
much as TNK2 can phosphorylate N-WASP; alternatively, SID-3 could be part of a
regulatory cascade and phosphorylate another protein in a pathway that ultimately
leads to VIRO-2 phosphorylation. The SID-3 kinase activity could also have other
sid-3 and viro-2 Support Orsay Virus Infection ®
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substrates unrelated to VIRO-2 that impact aspects of the Orsay virus life cycle. For
example, a link between sid-3 and sta-1, the C. elegans ortholog of mammalian Stat
genes, has been reported (43). We observed partial colocalization of ectopically ex-
pressed SID-3 and VIRO-2 supporting the possibility that they directly interact. Further-
more, RNAi knockdown of the C. elegans ortholog of NCK1, a known interacting partner
of both human TNK2 and N-WASP, reduced Orsay virus replication to levels similar to
that observed with knockdown of viro-2 or sid-3. Thus, we identiﬁed C. elegans
orthologs of multiple human genes that belong to a deﬁned pathway as critical for
Orsay virus infection. The studies herein reafﬁrm the tremendous value and potential of
model organism studies to elucidate novel mechanisms that are broadly important
across host species.
MATERIALS AND METHODS
C. elegans culture and maintenance. C. elegans strains N2, WM27 rde-1(ne219), RB2519 drh-
1(ok3495), VC787 sid-3(ok973), RB860 nck-1 (ok694), and VC40417 viro-2(gk627069) from the million
mutation project (26) were obtained from the Caenorhabditis Genetics Center (CGC) and maintained
under standard lab culture conditions unless otherwise speciﬁed. In brief, animals were fed Esche-
richia coli OP50 on nematode growth medium (NGM) plates in a 20°C incubator and moved every 3 days
to a new NGM plate seeded with E. coli OP50.
C. elegans genetics and crossing. The reporter strain ERT54 jyIs8 [Ppals-5::GFP; Pmyo-2::mCherry] (8)
was kindly provided by Emily Troemel (University of California, San Diego) and further crossed with the
WM27 rde-1(ne219) strain to generate strain WUM31 jyIs8 [Ppals-5::GFP; Pmyo-2::mCherry];rde-1(ne219).
Strains VC787 sid-3(ok973) and strain VC40417 viro-2(gk627069) were crossed with the WUM31 jyIs8;rde-1
strain, yielding strain WUM57 jyIs8;rde-1;sid-3(ok973) and strain WUM58 jyIs8;rde-1;viro-2(gk627069), re-
spectively. The sid-3(vir9) and viro-2(vir10) strains were crossed with the WUM28 virIs1;rde-1 strain,
yielding WUM59 virIs1;jyIs8;rde-1;sid-3(vir9) and WUM60 virIs1;jyIs8;rde-1;viro-2(vir10), respectively (Ta-
ble 1).
Orsay virus preparation, infection, and RNA extraction. Orsay virus was prepared by large-scale
liquid culture as described previously (4), ﬁltered through a 0.22-m ﬁlter, and stored at 80°C. For all
infection experiments, animals were bleached and then synchronized in M9 buffer (44) in 15-ml conical
tubes with constant rotation at room temperature for 16 h. Five hundred arrested larval stage 1 (L1)
larvae were seeded onto each well of a six-well plate with 20 l E. coli OP50 lawn. L1 larvae were allowed
to recover for 20 h at 20°C prior to infection. Orsay virus ﬁltrate was thawed in a 37°C water bath and
then diluted 1:10 with M9 buffer. For each well, 20 l of virus ﬁltrate was added into the middle of the
bacterial lawn and incubated at 20°C. Three days after infection, animals were collected into 1.5-ml
Eppendorf tubes by washing each well with 1 ml of M9 buffer and then pelleted by spinning for 1 min
at 3,000 rpm in a benchtop centrifuge. M9 supernatant was removed, and 350 l TRIzol reagent
(Invitrogen) was added to the tubes, and then the tubes were frozen in liquid nitrogen. For each
experiment, three replicate wells were used for each infection condition. Total RNA from infected animals
was extracted using Direct-zol RNA miniprep (Zymo Research) puriﬁcation according to the manufac-
turer’s protocol and eluted into 30 l of RNase/DNase-free water.
C. elegans feeding RNAi knockdown. RNAi feeding was used for gene knockdown as described
previously (45). E. coli strain HT115 carrying double-strand RNA expression cassettes for genes of interest
was induced using established conditions and then seeded into six-well NGM plates. dpy-3, sid-3, adr-2,
lst-4, dhs-7, mig-13, mig-2, wsp-1, and nck-1 RNAi clones were from the Ahringer RNAi library (46). To
construct the viro-2 feeding RNAi clone, a 1-kb genomic fragment of the gene was ampliﬁed by single
animal PCR using primers HJ245 (TGCGGATCCCATCAAGACTAC) and HJ246 (TACGGATCCAAGGGTTGGT
AGTGTTCCG). The PCR product was digested with BamHI, cloned into pL4440, and transformed in E. coli
HT115. Twenty arrested L1 drh-1 mutant or N2 animals were seeded into each well of a six-well plate.
After 72 h of RNAi feeding, Orsay virus was added to the plates as described above. At 48 h postinfection
(hpi) the infected C. elegans animals were collected, and 350 l of TRIzol (Invitrogen) was added to each
well for RNA extraction.
Orsay virus quantiﬁcation through real-time qRT-PCR. RNA extracted from infected animals was
subjected to one-step real-time quantitative reverse transcription-PCR (qRT-PCR) to quantify Orsay virus
replication as previously described (27). Brieﬂy, the extracted viral RNA was diluted 1:100, and 5 l was
used in a TaqMan fast virus one-step qRT-PCR with primers and probe Orsay_RNA2 that target the Orsay
RNA2 segment. Absolute Orsay virus RNA2 copy number was determined by comparison to a standard
curve generated using serial dilutions of Orsay virus RNA2 in vitro transcripts. Primers GW314 and GW315
and probe Orsay_RNA1 that target the Orsay virus RNA1 segment were used to quantify Orsay virus
RNA1 abundance (4). To control for variation in the number of animals, Orsay virus RNA levels were
normalized to an internal control gene cdc-42, levels of which are known to be constant throughout the
C. elegans life cycle (47). The means and standard deviations for three replicate wells are shown for all
experiments. Statistical testing was done by Student’s t test. Statistically signiﬁcant comparisons are
indicated as follows: *****, P  0.00005; ****, P  0.0005; ***, P  0.005; **, P  0.01; *, P  0.05; NS (for
not signiﬁcant with P  0.05).
Forward genetic screen for mutants unable to induce GFP expression following Orsay virus
infection. The jyIs8;rde-1 reporter strain was maintained on 10-cm plates seeded with 1 ml of E. coli
Jiang et al. ®
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OP50. Animals were grown to a stage with a high proportion of L4 larvae and were then collected
by washing the plates with water. Animals were then treated with 50 mM of ethane methylsulfonate
(EMS) for 4 h at 20°C with constant rotating. Animals were washed with M9 buffer and recovered on
plates for 2 h. L4 P0 animals were transferred to a new NGM plate and were allowed to lay F1 eggs.
F1 animals were washed away from plates after laying about 20 eggs for each animal. Hatched F2
animals were challenged with 800 l Orsay virus ﬁltrate per plate and screened for Viro mutants.
Two hermaphrodites of each mutant strain were backcrossed with eight males generated from
the unmutagenized jyIs8;rde-1 reporter strain. Their progenies were assessed for the Viro phenotype
to conﬁrm Mendelian genetics for these mutants. Similarly, Viro-1 and Viro-2 mutants were recip-
rocally crossed with each other to deﬁne the ability of their progeny to complement the Viro
phenotype.
Genetic mapping through F2 bulk segregant and CloudMap analysis. Viro-1 and Viro-2 mutants
were crossed with the WM27 rde-1(ne219) strain, and F1 progenies were chosen and transferred to
six-well plates. After 3 days, the F2 progenies were challenged with Orsay virus. A total of 72 F2 Viro
animals were picked off F1 plates and transferred to six-well plates. F2 plates were replicated after
1 day of laying eggs. The original F2 plates were challenged again with Orsay virus, and both
virus-induced GFP ﬂuorescence and Orsay virus RNA levels were assayed at 3 days postinfection.
Wells that yielded exclusively Viro animals and that yielded low RNA levels from replicated F2 plates
were pooled, and genomic DNA from pooled samples was extracted using a Qiagen genomic DNA
preparation kit according to the manufacturer’s protocol. DNA libraries were prepared using
TABLE 1 Transgenic strains used in this study
Lab
designation Strain name Relevant genotype
WM27 rde-1(ne219) [ rde-1(ne219)V]
ERT54 jyIs8 jyIs8[Ppals-5::GFP; Pmyo-2::mCherry]
WUM28 virIs1;rde-1(ne219) virIs1[PHIP::OrsayRNA1;PHIP::OrsayRNA2;Pmyo-2::YFP; rde-1(ne219) V]
WUM29 virIs1;jyIs8;rde-1(ne219) {virIs1[PHIP::OrsayRNA1;PHIP::OrsayRNA2; Pmyo-2::YFP]; jyIs8[Ppals-5::GFP;
Pmyo-2::mCherry]; rde-1(ne219) V}
WUM31 jyIs8;rde-1(ne219) {jyIs8[Ppals-5::GFP;Pmyo-2::mCherry]; rde-1(ne219) V}
WUM32 jyIs8;rde-1(ne219); virEx20[PHIP::RNA1WT-1] {virEx20[PHIP::OrsayRNA1WT-1; Pmyo-2::YFP]; jyIs8[Ppals-5::GFP;
Pmyo-2::mCherry];rde-1(ne219) V}
WUM33 jyIs8;rde-1(ne219); virEx21[PHIP::RNA1D601A-1] {virEx21[PHIP::OrsayRNA1D601A-1; Pmyo-2::YFP]; jyIs8[Ppals-5::GFP;
Pmyo-2::mCherry];rde-1(ne219) V}
WUM45 sid-3(vir9) {jyIs8[Ppals-5::GFP; Pmyo-2::mCherry]; rde-1(ne219) V; sid-3(vir9)X}
WUM46 viro-2(vir10) {jyIs8[Ppals-5::GFP; Pmyo-2::mCherry]; rde-1(ne219) V; viro-2(vir10)III}
WUM47 Viro-3 Not assigned
WUM51 sid-3(vir9); virEx23[PHIP::RNA1WT-1] {virEx23[PHIP::OrsayRNA1;Pmyo-2::YFP]; jyIs8[Ppals-5::GFP; Pmyo-2::mCherry];
rde-1(ne219) V; sid-3(vir9)X}
WUM52 sid-3(vir9); virEx24[PHIP::RNA1WT-2] {virEx24[PHIP::OrsayRNA1;Pmyo-2::YFP]; jyIs8[Ppals-5::GFP; Pmyo-2::mCherry];
rde-1(ne219) V; sid-3(vir9)X}
WUM54 sid-3(vir9); virEx26[PHIP::RNA1D601A-1] {virEx26[PHIP::OrsayRNA1D601A;Pmyo-2::YFP]; jyIs8[Ppals-5::GFP; Pmyo-2::mCherry];
rde-1(ne219)V; sid-3(vir9)X}
WUM55 sid-3(vir9);virEx27[PHIP::RNA1D601A-2] {virEx27[PHIP::OrsayRNA1D601A;Pmyo-2::YFP]; jyIs8[Ppals-5::GFP; Pmyo-2::mCherry];
rde-1(ne219)V; sid-3(vir9)X}
WUM57 sid-3(ok973) {jyIs8[Ppals-5::GFP; Pmyo-2::mCherry]; rde-1(ne219) V; sid-3(ok973)X}
WUM58 viro-2(gk627069) {jyIs8[Ppals-5::GFP; Pmyo-2::mCherry]; rde-1(ne219) V; viro-2(gk627069) III}
WUM59 virIs1;jyis8;rde-1(ne219);sid-3(vir9) {virIs1[PHIP::OrsayRNA1;PHIP::OrsayRNA2; Pmyo-2::YFP]; jyIs8[Ppals-5::GFP;
Pmyo-2::mCherry]; rde-1(ne219) V;sid-3(vir9)X}
WUM60 virIs1;jyis8;rde-1(ne219);viro-2(vir10) {virIs1[PHIP::OrsayRNA1;PHIP::OrsayRNA2; Pmyo-2::YFP]; jyIs8[Ppals-5::GFP;
Pmyo-2::mCherry]; rde-1(ne219) V; viro-2(vir10) III}
WUM61 virEx28[Psur-5::sid-3::YFP; Psur-5::viro-2::mCherry];
rde-1
{virEx28[Psur-5::sid-3::YFP;Psur-5::viro-2::mCherry]; rde-1(ne219)V; }
WUM64 sid-3(vir9);virEx31[Psur-5::sid-3] {virEx31[Psur-5::sid-3;Pmyo-3::mCherry]; jyIs8[Ppals-5::GFP; Pmyo-2::mCherry];
rde-1(ne219)V; sid-3(vir9)X}
WUM65 sid-3(vir9);virEx32[Psur-5::sid-3K139A] {virEx32[Psur-5::sid-3K139A;Pmyo-3::mCherry]; jyIs8[Ppals-5::GFP; Pmyo-2::mCherry];
rde-1(ne219)V; sid-3(vir9)X}
WUM66 sid-3(vir9); virEx33[Psur-5::sid-3::mCherry] {virEx33[Psur-5::sid-3::mCherry;Pmyo-2::YFP]; jyIs8[Ppals-5::GFP; Pmyo-2::mCherry];
rde-1(ne219)V; sid-3(vir9)X}
WUM67 sid-3(vir9); virEx34[Psur-5::sid-3K139A::mCherry] {virEx34[Psur-5::sid-3K139A::mCherry;Pmyo-2::YFP]; jyIs8[Ppals-5::GFP;
Pmyo-2::mCherry]; rde-1(ne219)V; sid-3(vir9)X}
WUM68 viro-2(vir10);virEx35[Psur-5::viro-2] {virEx35[Psur-5::viro-2;Pmyo-3::mCherry]; jyIs8[Ppals-5::GFP; Pmyo-2::mCherry];
rde-1(ne219)V; viro-2(vir10)III}
WUM69 viro-2(gk627069);virEx36[Psur-5::viro-2::mCherry] {virEx36[Psur-5::viro-2::mCherry;Pmyo-2::YFP]; jyIs8[Ppals-5::GFP; Pmyo-2::mCherry];
rde-1(ne219)V; viro-2(gk627069)III}
WUM71 sid-3(vir9); viro-2(vir10) {jyIs8[Ppals-5::GFP; Pmyo-2::mCherry]; rde-1(ne219) V; sid-3(vir9)X; viro-2(vir10)III}
WUM72 nck-1(ok694) {jyIs8[Ppals-5::GFP; Pmyo-2::mCherry]; rde-1(ne219) V; nck-1(ok694)X}
sid-3 and viro-2 Support Orsay Virus Infection ®
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NEB-Next library preparation kit (New England Biolabs) and then sequenced using Illumina Hiseq
2500. The raw sequence data were analyzed using the pipeline CloudMap for C. elegans gene
mapping (16).
Plasmid construction for gene overexpression. To construct the sid-3 expression plasmid (Psur-
5::sid-3), the entire sid-3 gene and 500 bp of its native 3= untranslated region (3= UTR) were ampliﬁed from
fosmid WRM061cD03. The PCR product was digested by BamHI and SacII and was then ligated into the
plasmid containing the sur-5 promoter. To generate the sid-3 catalytic mutant expression plasmid
(Psur-5::sid-3K139A), site-directed mutagenesis was performed to introduce a lysine-to-alanine (K139A)
mutation in the SID-3 kinase domain. C-terminal mCherry fusion constructs of both the wild-type SID-3
and K139A mutant were generated by overlapping PCR. Psur-5::viro-2 and Psur-5::viro-2::mCherry were
generated in an analogous fashion.
Ectopic trans-complementation with plasmids encoding SID-3 and VIRO-2. For rescue of Viro-1,
a fosmid (WRM061cD03) or an expression plasmid containing the sid-3 gene was injected into the mutant
strain at a concentration of 50 ng/l along with 5 ng/l of Pmyo-3::mCherry as a transgenic marker and
50 ng/l of DNA ladder (NEB) to help establish the array (48). For rescue of Viro-2, the genomic fragment
of viro-2 containing 3 kb upstream of the promoter region and 500 bp downstream of the 5= UTR or a
plasmid that expresses viro-2 was injected at a concentration of 12.5 ng/l along with 2.5 ng/l of
Pmyo-3::mCherry and 87.5 ng/l of DNA ladder. The stable transgenic array containing F2 animals was
selected, challenged with Orsay virus, and assayed for GFP ﬂuorescence and virus replication by qRT-PCR.
The expression levels of the virus-induced gene F26F2.1 in the sid-3 rescue experiment were measured
by a two-step real-time quantitative PCR using TaqMan gene expression assays (Applied Biosystems)
according to the manufacturer’s protocol.
Epiﬂuorescence and confocal microscopy. The microscopic visual scanning analysis for Orsay virus
infection was carried out using a Leica stereo ﬂuorescence microscope. Images of C. elegans mutant
infections were acquired using a Zeiss Axioskop inverted ﬂuorescence microscope. Brieﬂy, young adult
to adult C. elegans animals were anesthetized with 1 mM levimisol and then put on a 2% dry agarose pad
with a coverslip (5 by 5 cm) on top. Images were acquired from both ﬂuorescence channels and
bright-ﬁeld channels. Confocal images for colocalization of SID-3 and VIRO-2 were acquired using a Zeiss
LSM 880 confocal microscope with Airyscan (Carl Zeiss, Inc., Thornwood, NY) equipped with a 63,
1.4-numerical-aperture Zeiss Plan Apochromat oil objective. Quantiﬁcation of mCherry expression was
performed by image analysis with ImageJ 1.51j8.
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